Skip to main content
. Author manuscript; available in PMC: 2018 Nov 13.
Published in final edited form as: Mult Scler. 2017 Sep 22;24(13):1760–1769. doi: 10.1177/1352458517732842

Table 1.

Demographic and clinical characteristics.

Value Study 1
Study 2
Active
(n = 15)
Control
(n = 20)
p value Active
(n = 15)
Sham
(n = 12)
p value
Age (mean ± SD) 53.4 ± 8.0 51.0 ± 12.7 0.50 44.8 ± 16.2 43.4 ± 16.2 0.83
Gender (% female) 66 65 1.00 53 67 0.70
Race (% African American) 13 15 0.80 33 33 1.00
Ethnicity (% Hispanic) 0 10 0.50 14 12 0.99
Handedness (% right-handed) 92 95 0.69 73 92 0.43
Years education (mean ± SD) 15.9 ± 2.6 14.8 ± 2.0 0.19 15.5 ± 2.0 16.1 ± 1.8 0.41
Years with MS (mean ± SD) 15.6 ± 8.9 15.7 ± 9.6 0.99 15.8 ± 9.4 13.3 ± 11.3 0.51
Diagnosis (% RRMS) 20 75 0.002 40 58 0.45
EDSS (median and range) 6.0 (1.0–8.0) 4.0a (2.0–7.0) 0.18 6.0 (0.0–7.0) 3.5 (0.0–8.5) 0.89
Baseline FSS (% clinical fatigue) 66 75 0.71 50 76 0.15
Baseline PROMIS Fatigue (mean ± SD) 26.9 ± 7.6 23.85 ± 5.8 0.19 26.6 ± 9.0 22.9 ± 7.9 0.30
Baseline BDI category (% Category 1) 50 65 0.15 50 64 0.84

SD: standard deviation; MS: multiple sclerosis; RRMS: relapsing–remitting multiple sclerosis; EDSS: Expanded Disability Status Scale; FSS: Fatigue Severity Scale; PROMIS: Patient-Reported Outcomes Measurement Information System; BDI: Beck Depression Inventory.

a

n = 8 due to missing EDSS data for Study 1 Controls.